Publications by authors named "Xavier Vige"

Claim this Profile
A
A 3D Human Liver Model of Nonalcoholic Steatohepatitis.
Marion Duriez, Agnes Jacquet, Lucile Hoet, Sandrine Roche, Marie-Dominique Bock

J Clin Transl Hepatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data on synthesis, ADME and pharmacological properties and early safety pharmacology evaluation of a series of novel NURR1/NOT agonist potentially useful for the treatment of Parkinson's disease.
André Malanda, Pierre-Yves Abécassis, Pascal Barnéoud, Pascale Brunel, Véronique Taupin

Data Brief· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease.
Dominique Lesuisse, André Malanda, Jean-François Peyronel, Yannick Evanno, Patrick Lardenois

Bioorg Med Chem Lett· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro evaluation of the internalization and toxicological profile of silica nanoparticles and submicroparticles for the design of dermal drug delivery strategies.
Sara Vicente, Claudia Moia, Huijun Zhu, Xavier Vigé

J Appl Toxicol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia.
Guy Griebel, Philippe Pichat, Denis Boulay, Vanessa Naimoli, Lisa Potestio

Sci Rep· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin EP2 receptor signaling protects human trabecular meshwork cells from apoptosis induced by ER stress through down-regulation of p53.
Georges Kalouche, Céline Boucher, Annick Coste, Laurent Debussche, Cécile Orsini

Biochim Biophys Acta· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of Prostaglandin FP and EP2 Receptors Differently Modulates Myofibroblast Transition in a Model of Adult Primary Human Trabecular Meshwork Cells.
Georges Kalouche, Fanny Beguier, Michael Bakria, Stéphane Melik-Parsadaniantz, Caroline Leriche

Invest Ophthalmol Vis Sci· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia.
Denis Boulay, Philippe Pichat, Gihad Dargazanli, Genevieve Estenne-Bouhtou, Jean Paul Terranova

Pharmacol Biochem Behav· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.
Bruno Biton, Olivier E Bergis, Frédéric Galli, Alain Nedelec, Alistair W Lochead

Neuropsychopharmacology· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne-Bouhtou, Annick Coste, Christophe Lanneau

Neuropsychopharmacology· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
Xavier Emonds-Alt, Vincenzo Proietto, Régis Steinberg, Florence Oury-Donat, Xavier Vigé

J Pharmacol Exp Ther· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis